Comparison

GSK3368715 (dihydrochloride) European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 100 mg
Quantity options 100 mg 10mM/1mL 10 mg 1 mg 25 mg 50 mg 5 mg
Item no. HY-128717A-100mg
CASRN 1628925-77-8
eClass 6.1 30220300
eClass 9.0 32160605
Available
Alias EPZ019997 (dihydrochloride)
Purity 99.80
Product Description
GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity[1].
StorageTemperature
4°C (Powder, stored under nitrogen)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
439.46
Clinical_Information
Phase 1
Manufacturers Research Area
Cancer
Solubility
DMSO : 230 mg/mL (ultrasonic)|H2O : 140 mg/mL (ultrasonic)
Manufacturers Target
Histone Methyltransferase
Isoform
PRMT1; PRMT3; PRMT4; PRMT6; PRMT8
Pathway
Epigenetics

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close